Results of a Phase II trial with weekly administration of TCF and concurrent radiotherapy

Neoadjuvant therapy with weekly docetaxel and cisplatin, 5-fluorouracil continuous infusion, and concurrent radiotherapy in patients with locally advanced esophageal cancer produced a high percentage of long-lasting pathological complete response: A phase 2 study.

PASINI, Felice;DE MANZONI, Giovanni;CORDIANO, Claudio
2013

Abstract

Results of a Phase II trial with weekly administration of TCF and concurrent radiotherapy
cancer; esohagus; chemotherap; Radiotherapy
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11562/523352
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 46
social impact